In Vivo Brain Reprogramming with Precise Spatial and Temporal Controls
GT Biosciences is developing ligand conjugated lipid nanoparticles for targeted brain gene editing, allowing controllable Cas9 and sgRNA activation via systematic injection.
GT Biosciences is developing ligand conjugated lipid nanoparticles for targeted brain gene editing, allowing controllable Cas9 and sgRNA activation via systematic injection.